Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and ...
Ticketed overseas fans will get expedited visa appointments for the World Cup, while host city executives have been left ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Ultragenyx and Mereo Biopharma, are expecting to report results from two phase 3 trials for Osteogenesis Imperfecta. Read ...
West Garfield Park residents are expected to live on average until 67 years old, compared to 87 in the Loop. This is the ...
Myonex announced today that Greg Lavin, Chief Financial Officer (CFO), will assume the role of Chief Executive Officer (CEO) ...
Alphonse Pierre’s Off the Dome column covers songs, mixtapes, albums, scenes, snippets, movies, Meek Mill tweets, fashion ...
When Tim Hunt was invited to a meeting with Robert F. Kennedy Jr. in early March, the Department of Health and Human Services ...
In that scenario, Maduro would emerge as the survivor who bested Trump and showed that American influence in the Western Hemisphere is limited at best. Removing Maduro, on the other hand, would ...
Chang: In Mastercard's view, breakthrough innovation is set to redefine and reshape the future of business. Over the years, ...
New lecanemab findings highlight the safety and potential benefits of subcutaneous administration for initiation dosing, the ...
The ASC industry has been steadily growing throughout 2025, with at least 74 ASCs announced, completed or constructed in the first half of the year alone. While the industry overall is projected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results